Diabetes Type 2

Incretin drugs, which offer ease of use, very little hypoglycemia, and no weight gain (or even weight loss) seem to be an ideal therapy. But 80% to 90% of patients don’t stay on them. Why not?

Diabetes Type 2

A paw on the leg, a wet nose in the night -- both have helped diabetes patients avoid the consequences of peaks and troughs in blood sugar. More on how they do it, here.

You have probably read the news by now -- but do you recall the most remarkable rates of decline? Was it in MI? Lower-limb amputations? Death after hyperglycemic crisis? Check your memory with this quick quiz.

Sodium glucose cotransporter 2 inhibitors act independently of insulin level and so can be used at various stages of type 2 diabetes disease progression. Latest findings, here.

Patients aged 80 years or older were more than twice as likely to visit the ED and nearly 5 times as likely to be hospitalized for insulin-related hypoglycemia than those aged 45 to 64 years.

In a US study, diabetes was shown to significantly increase the odds of having restless legs syndrome and a history of diabetes was the most consistent risk factor linked to the disorder.

The benefits of statin therapy no longer stand uncontested as they did early in the lifecycle of the class. The pro and con camps each can point to science, but in the end it's about personalized medicine.

Certain modifiable risk factors affect variability in home blood pressure in patients with type 2 diabetes mellitus.


Subscribe to
Please Wait 20 seconds or click here to close